Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:30 PM
Ignite Modification Date:
2025-12-24 @ 3:30 PM
NCT ID:
NCT03971292
Eligibility Criteria:
Inclusion criteria common to all participants:
* Patient minor or major
* Patient suffering from a pathology studied in the laboratory by high throughput sequencing: intellectual disability, myopathies, neurosensory disease (Bardet-Biedl syndrome, retinitis pigmentosa, ....), DNA repair diseases (Cockayne syndrome, ...)
* Sampling allowing the extraction of available RNA (or RNA available in the bank)
* Patient (or its legal representative) having already given their consent, on the one hand for carrying out genetic analyzes to determine the cause of their disease, and on the other hand for the conservation of part of their non used for further use in order to continue diagnostic investigations in the light of evolving knowledge and for research purposes.
* Patient (or its legal representative) agreeing to use data from his medical file and those associated with genetic diagnosis for research purposes
* Patient affiliated to a social security scheme Inclusion criteria for the test phase
* Pertogenous mutation (s) known Inclusion criteria for the prospective phase
* Magnetic molecular diagnosis, after the usual investigations (high-throughput sequencing of a panel of genes on genomic DNA, sequencing of exome, or even genome.
Non-inclusion criteria:
◾ Refusal of the patient (or his / her legal representative) to participate in the study.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03971292
Study Brief:
Protocol Section:
NCT03971292